Daniel J. Bratton

4.5k total citations · 2 hit papers
60 papers, 3.2k citations indexed

About

Daniel J. Bratton is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Daniel J. Bratton has authored 60 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Physiology, 25 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Daniel J. Bratton's work include Obstructive Sleep Apnea Research (22 papers), Asthma and respiratory diseases (14 papers) and Neuroscience of respiration and sleep (11 papers). Daniel J. Bratton is often cited by papers focused on Obstructive Sleep Apnea Research (22 papers), Asthma and respiratory diseases (14 papers) and Neuroscience of respiration and sleep (11 papers). Daniel J. Bratton collaborates with scholars based in United Kingdom, Switzerland and United States. Daniel J. Bratton's co-authors include James Kennedy, Malcolm Kohler, Thomas Gaisl, John Stradling, Frank C. Albers, Andrew Nunn, Geoffrey Chupp, Annette Wons, Eric Bradford and Linda Nelsen and has published in prestigious journals such as JAMA, PLoS ONE and CHEST Journal.

In The Last Decade

Daniel J. Bratton

59 papers receiving 3.1k citations

Hit Papers

Defining a Standard for Particle Swarm Optimization 2007 2026 2013 2019 2007 2017 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel J. Bratton United Kingdom 21 1.8k 1.1k 764 549 297 60 3.2k
Francesco Benedetto Italy 32 554 0.3× 575 0.5× 157 0.2× 177 0.3× 8 0.0× 175 5.2k
Mohamed R. Ali Egypt 43 696 0.4× 403 0.4× 110 0.1× 161 0.3× 47 0.2× 316 6.5k
Nicos Maglaveras Greece 30 194 0.1× 766 0.7× 82 0.1× 875 1.6× 59 0.2× 308 5.3k
Michael B. Gotway United States 41 306 0.2× 1.8k 1.7× 26 0.0× 1.5k 2.7× 15 0.1× 144 6.8k
James Baker United States 30 1.1k 0.6× 833 0.8× 7 0.0× 736 1.3× 49 0.2× 149 3.8k
J. M. Bishop United Kingdom 29 175 0.1× 1.1k 1.0× 66 0.1× 241 0.4× 65 0.2× 97 2.7k
Wei Lv China 35 326 0.2× 248 0.2× 49 0.1× 32 0.1× 14 0.0× 176 3.7k
Edward J. Ciaccio United States 41 163 0.1× 524 0.5× 25 0.0× 650 1.2× 16 0.1× 219 6.1k
Jiguo Cao Canada 24 155 0.1× 274 0.3× 35 0.0× 394 0.7× 54 0.2× 120 2.4k
Rajiv Raman India 34 175 0.1× 403 0.4× 15 0.0× 1.2k 2.2× 24 0.1× 232 8.8k

Countries citing papers authored by Daniel J. Bratton

Since Specialization
Citations

This map shows the geographic impact of Daniel J. Bratton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Bratton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Bratton more than expected).

Fields of papers citing papers by Daniel J. Bratton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Bratton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Bratton. The network helps show where Daniel J. Bratton may publish in the future.

Co-authorship network of co-authors of Daniel J. Bratton

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Bratton. A scholar is included among the top collaborators of Daniel J. Bratton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Bratton. Daniel J. Bratton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albers, Frank C., Alberto Papi, Camille Taillé, et al.. (2019). Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA. Respiratory Research. 20(1). 169–169. 38 indexed citations
2.
Yancey, Steven W., Frank C. Albers, Daniel J. Bratton, et al.. (2019). Efficacy Of 100 Mg SC Mepolizumab For Severe Eosinophilic Asthma (SEA) Across Blood Eosinophil Counts: Meta-Analysis. Journal of Allergy and Clinical Immunology. 143(2). AB101–AB101. 1 indexed citations
3.
Humbert, Marc, Frank C. Albers, Daniel J. Bratton, et al.. (2019). Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility. Respiratory Medicine. 154. 69–75. 31 indexed citations
4.
Shrimanker, Rahul, Oliver N. Keene, Daniel J. Bratton, et al.. (2019). Characterisation of Exacerbations of Severe Eosinophilic Asthma on Mepolizumab Compared to Placebo. A2671–A2671. 1 indexed citations
5.
Schlatzer, Christian, Daniel J. Bratton, Esther I. Schwarz, et al.. (2018). Effect of continuous positive airway pressure therapy on circadian patterns of cardiac repolarization in patients with obstructive sleep apnoea: data from a randomized trial. Journal of Thoracic Disease. 10(8). 4940–4948. 3 indexed citations
6.
Gaisl, Thomas, Cecilia Giunta, Daniel J. Bratton, et al.. (2017). Obstructive sleep apnoea and quality of life in Ehlers-Danlos syndrome: a parallel cohort study. Thorax. 72(8). 729–735. 33 indexed citations
7.
Kuhn, Eric, Esther I. Schwarz, Daniel J. Bratton, Valentina A. Rossi, & Malcolm Kohler. (2017). Effects of CPAP and Mandibular Advancement Devices on Health-Related Quality of Life in OSA. CHEST Journal. 151(4). 786–794. 80 indexed citations
8.
Gaisl, Thomas, Annette Wons, Valentina A. Rossi, et al.. (2016). Simulated Obstructive Sleep Apnea Increases P-Wave Duration and P-Wave Dispersion. PLoS ONE. 11(4). e0152994–e0152994. 14 indexed citations
10.
Schlatzer, Christian, et al.. (2016). ECG risk markers for atrial fibrillation and sudden cardiac death in minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised trial. BMJ Open. 6(3). e010150–e010150. 13 indexed citations
11.
Simpson, Rosalind, Ruth Murphy, Daniel J. Bratton, et al.. (2016). Systemic therapy for vulval Erosive Lichen Planus (the ‘hELP’ trial): study protocol for a randomised controlled trial. Trials. 17(1). 2–2. 17 indexed citations
12.
McMillan, Alison, Daniel J. Bratton, Rita Faria, et al.. (2015). A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICT. Health Technology Assessment. 19(40). 1–188. 42 indexed citations
13.
Gaisl, Thomas, Daniel J. Bratton, & Malcolm Kohler. (2015). The impact of obstructive sleep apnoea on the aorta. European Respiratory Journal. 46(2). 532–544. 55 indexed citations
15.
Bratton, Daniel J., Babak Choodari‐Oskooei, & Patrick Royston. (2015). A Menu-driven Facility for Sample-size Calculation in Multiarm, Multistage Randomized Controlled Trials with Time-to-event Outcomes: Update. The Stata Journal Promoting communications on statistics and Stata. 15(2). 350–368. 10 indexed citations
16.
McMillan, Alison, Daniel J. Bratton, Rita Faria, et al.. (2014). Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial. The Lancet Respiratory Medicine. 2(10). 804–812. 163 indexed citations
17.
Kahan, Brennan C, Suzie Cro, Caroline J Doré, et al.. (2014). Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials. Trials. 15(1). 456–456. 75 indexed citations
18.
Kohler, Malcolm, Sonya Craig, Justin Pepperell, et al.. (2013). CPAP Improves Endothelial Function in Patients With Minimally Symptomatic OSA. CHEST Journal. 144(3). 896–902. 66 indexed citations
20.
Bratton, Daniel J. & Andrew Nunn. (2011). Alternative approaches to tuberculosis treatment evaluation: the role of pragmatic trials. Trials. 12(Suppl 1). A96–A96. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026